Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.66 |
| ▸ | ALPI | P09923 | 1/20 | 0.66 |
| ▸ | PKM | P14618 | 1/20 | 0.66 |
| ▸ | XIAP | P98170 | 1/20 | 0.66 |
| ▸ | TPH1 | P17752 | 1/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | EGFR | P00533 | 1/20 | 0.56 |
| ▸ | LCK | P06239 | 1/20 | 0.56 |
| ▸ | FYN | P06241 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | HTR2A | P28223 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | GRB2 | P62993 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6777440 | 1.00 | SLC7A5 (0.67) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL93538 | 1.00 | SLC7A5 (0.67) | SLC7A5PTGS1ALPIPKMXIAP | |
| Ammonia Solution, Strong SCHEMBL18166509 | 0.98 | SLC7A5 (0.65) | SLC7A5PTGS1ALPIPKMXIAP | |
| Hydrochloric Acid SCHEMBL28673608 | 0.98 | SLC7A5 (0.65) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL31021359 | 0.98 | SLC7A5 (0.65) | SLC7A5PTGS1ALPIPKMXIAP | |
| Hydrochloric Acid SCHEMBL30947766 | 0.98 | SLC7A5 (0.65) | SLC7A5PTGS1ALPIPKMXIAP | |
| Hydrochloric Acid SCHEMBL28673609 | 0.98 | SLC7A5 (0.65) | SLC7A5PTGS1ALPIPKMXIAP | |
| Ammonia Solution, Strong SCHEMBL18166510 | 0.98 | SLC7A5 (0.65) | SLC7A5PTGS1ALPIPKMXIAP | |
| Alanine SCHEMBL20450553 | 0.93 | SLC7A5 (0.59) | SLC7A5PTGS1ALPIPKMXIAP | |
| Iodofalan SCHEMBL28790138 | 0.92 | SLC7A5 (0.57) | SLC7A5PTGS1ALPIPKMXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3879 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612440-B2 | Modified bovine G-CSF polypeptides and their uses | ELANCO US INC. (US) | 2026-04-28 | — | — | US | claimed |
| US-20260007763-A1 | PEGYLATED ANTIBODY HYDROXYL-BEARING DRUG CONJUGATE | SHENZHEN ENDURING BIOTECH, LTD. (CN) | 2026-01-08 | — | — | US | claimed |
| EP-3694535-B1 | PORCINE G-CSF VARIANTS AND THEIR USES | ELANCO US INC (US) | 2025-11-26 | — | — | EP | claimed |
| EP-4631972-A1 | SITE-SPECIFIC COUPLED PEGYLATED INTERLEUKIN-2 MUTANT WITH RECEPTOR AFFINITY PREFERENCE AND USE THEREOF | Nanjing Novoacine Biotechnology Co., Ltd. (CN) | 2025-10-15 | — | — | EP | claimed |
| EP-3788149-B1 | A METHOD FOR OPTIMIZING ANTIBODY EXPRESSION | AMBRX INC (US) | 2025-08-27 | — | — | EP | claimed |
| EP-3789395-B1 | PEGYLATION OF FGF21 | BRISTOL MYERS SQUIBB CO (US) | 2025-08-27 | — | — | EP | claimed |
| US-20250228955-A1 | PLATFORM TECHNOLOGY FOR BISPECIFIC ANTIGENBINDING PROTEINS | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2025-07-17 | — | — | US | claimed |
| US-20250230198-A1 | COMPOSITIONS AND METHODS FOR MAKING AND USING PROTEIN NANOWIRES WITH TUNABLE FUNCTIONALITY | YALE UNIVERSITY | 2025-07-17 | — | — | US | claimed |
| WO-2025134068-A1 | ANTIBODY DRUG CONJUGATES TARGETING PROTEINOPATHIES, AND USES THEREOF | AC IMMUNE SA (CH) | 2025-06-26 | — | — | WO | claimed |
| CN-120076831-A | Anti-ROR 1 antibodies and antibody conjugates, compositions comprising anti-ROR 1 antibodies or antibody conjugates, and methods of making and using anti-ROR 1 antibodies and antibody conjugates | 苏特罗生物制药公司 | 2025-05-30 | — | — | CN | claimed |
| WO-2007021297-A9 | COMPOSITIONS OF tRNA AND USES THEREOF | AMBRX INC (US) | 2007-06-28 | — | — | WO | claimed |
| WO-2007048127-A9 | FC LABELING FOR IMMUNOSTAINING AND IMMUNOTARGETING | SCRIPPS RESEARCH INST (US) | 2007-06-07 | — | — | WO | claimed |
| US-20070122408-A1 | Fc Labeling for Immunostaining and Immunotargeting | THE SCRIPPS RESEARCH INSTITUTE (US) | 2007-05-31 | — | — | US | claimed |
| WO-2007048127-A2 | FC LABELING FOR IMMUNOSTAINING AND IMMUNOTARGETING | THE SCRIPPS RESEARCH INSTITUTE (US) | 2007-04-26 | — | — | WO | claimed |
| WO-2007021297-A1 | COMPOSITIONS OF tRNA AND USES THEREOF | AMBRX, INC. (US) | 2007-02-22 | — | — | WO | claimed |
| WO-2007008603-A1 | MONOMETHYLVALINE COMPOUNDS HAVING PHENYLALANINE SIDE-CHAIN MODIFICATIONS AT THE C-TERMINUS | SEATTLE GENETICS, INC. (US) | 2007-01-18 | — | — | WO | claimed |
| US-20060189529-A1 | Linked to polyoxyethylene glycol via oximination; improved half-life | AMBRX, INC. (US) | 2006-08-24 | — | — | US | claimed |
| WO-2006069220-A2 | MODIFIED HUMAN GROWTH HORMONE | AMBRX, INC. (US) | 2006-06-29 | — | — | WO | claimed |
| WO-2006068802-A2 | COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF | AMBRX, INC. (US) | 2006-06-29 | — | — | WO | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |